A novel frameshift variant in LAMP2 gene mimicking choroideremia carrier retinopathy

被引:0
|
作者
Narayan, Akshay [1 ]
Taylor, Laura J. [1 ,2 ]
Sperring, Sian [1 ]
Shanks, Morag [3 ]
Clouston, Penny [3 ]
MacLaren, Robert E. [1 ,2 ]
Cehajic-Kapetanovic, Jasmina [1 ,2 ]
机构
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford Eye Hosp, Oxford OX3 9DU, England
[2] Univ Oxford, Nuffield Lab Ophthalmol, Oxford, England
[3] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Oxford Reg Genet Lab, Oxford, England
关键词
LAMP2; Danon disease; lysosomal storage disorder; REP-1; choroideremia; CARDIOMYOPATHY; DEFICIENCY; LYSOSOMES; THERAPY;
D O I
10.1080/13816810.2024.2404148
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Danon disease is a rare, multisystemic X-linked dominant disorder caused by variants in the LAMP2 gene. It can be associated with retinal degeneration, but this is not well characterized. Here we describe a late presentation of a mild retinal phenotype, initially diagnosed as choroideremia carrier, associated with a novel variant in the LAMP2 gene. Methods: Retrospective analysis of the case included medical history, ophthalmic examination, multimodal retinal imaging, and microperimetry. Genetic testing was conducted to establish the molecular diagnosis. Results: A 54-year-old female presented with worsening night vision, without any family history. BCVA was 6/6 bilaterally and fundus examination showed light peripheral pigmentary changes bilaterally. FAF demonstrated a widespread speckled pattern and OCT revealed hyper-reflective spots in the outer nuclear layer. Differentials included non-genetic and genetic causes, suspected of being a manifesting choroideremia carrier. However, initial genetic testing by targeted analysis of retinal disorders did not detect a pathogenic variant. Further systems review revealed that the patient had previously been diagnosed with dilated cardiomyopathy, mini-stroke and partial deafness. Subsequent whole mitochondrial genome sequencing analysis did not detect any pathogenic variants too. Finally, whole exome sequencing with targeted analysis of a panel of hypertrophic cardiomyopathy genes identified a novel pathogenic heterozygous variant (c.925del, p.(Ser309fs)) in the LAMP2 gene, confirming the diagnosis of X-linked Danon disease. Conclusion: Recording previous medical history and extraocular symptoms is crucial. The similarity in choroideremia carrier and Danon disease retinal phenotypes suggests a possible common pathway in these two genes where pathogenic variants lead to retinal pigment epithelium degeneration.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Identification of a novel LAMP2 gene variant: key role of genetic testing in the diagnosis of Danon disease
    Novelli, V.
    Bisignani, A.
    Pelargonio, G.
    Primiano, G.
    Tiziano, F. D.
    Zeppilli, P.
    Servidei, S.
    Crea, F.
    Genuardi, M. G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 551 - 551
  • [2] A novel truncating variant in the LAMP2 gene in a young woman with hypertrophic cardiomyopathy and variable clinical course in the family
    Michalak, Ewa
    Franaszczyk, Maria
    Sobieszczanska-Malek, Malgorzata
    Karcz, Maciej
    Szymanska, Sylwia
    Szczygiel, Justyna
    Lutynska, Anna
    Ploski, Rafal
    Bilinska, Zofia T.
    ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (06) : 1464 - 1469
  • [3] Identification of Two Novel LAMP2 Gene Mutations in Danon Disease
    Csanyi, Beata
    Popoiu, Anca
    Hategan, Lidia
    Hegedus, Zoltan
    Nagy, Viktoria
    Racz, Katalin
    Hogye, Marta
    Saghy, Laszlo
    Ivanyi, Bela
    Csanady, Miklos
    Forster, Tamas
    Sepp, Robert
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (11) : 1355.e23
  • [4] Danon disease due to a novel splice mutation in the LAMP2 gene
    Nadeau, Amelie
    Therrien, Christian
    Karpati, George
    Sinnreich, Michael
    MUSCLE & NERVE, 2008, 37 (03) : 338 - 342
  • [5] Danon disease due to a novel splice mutation in the LamP2 gene
    Nadeau, Amelie
    Therrien, Christian
    Karpati, George
    Sinnreich, Michael
    NEUROLOGY, 2008, 70 (11) : A311 - A311
  • [6] A novel nonsense LAMP2 variant associated with Danon disease in a pediatric male: A case report
    Castillo-Garcia, Daniela
    Ceron-Rodriguez, Magdalena
    Patricio Acosta-Rodriguez-Bueno, Carlos
    Aguirre-Hernandez, Jesus
    Almanza-Aranda, Judith
    Rafael Murillo-Eliosa, Juan
    Valencia-Mayoral, Pedro
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S23 - S23
  • [7] Identification of a novel splicing-altering LAMP2 variant in a Chinese family with Danon disease
    Fu, Di
    Wang, Shuai
    Luo, Yonghong
    Wu, Sha
    Peng, Daoquan
    ESC HEART FAILURE, 2023, 10 (04): : 2479 - 2486
  • [8] A putative frameshift variant in the CHM gene is associated with an unexpected splicing alteration in a choroideremia patient
    Fioretti, Tiziana
    Ungari, Silvana
    Savarese, Maria
    Cattaneo, Fabio
    Pirozzi, Enza
    Esposito, Gabriella
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (11):
  • [9] Extension of the clinical spectrum of Danon's disease.: A novel missense mutation in the splice variant B of the LAMP2 gene leads to myopathy, with mild cardiac abnormalities, retinopathy and no evident mental retardation
    van der Kooi, A.
    Aronica, E.
    van Doorn, P.
    Wokke, J.
    van Langen, I.
    Langerhorst, C.
    Lekanne dit Deprez, R.
    Dekker, L.
    de Visser, M.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 862 - 862
  • [10] Danon disease: A focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency
    Majer, F.
    Vlaskova, H.
    Krol, L.
    Kalina, T.
    Kubanek, M.
    Stolnaya, L.
    Dvorakova, L.
    Elleder, M.
    Sikora, J.
    GENE, 2012, 498 (02) : 183 - 195